MetLife, Inc. (MET)

Every figure this model derived for MET, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 27,317,000,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
equity 27,441,000,000 StockholdersEquity 2026-06-30
interest expense 1,091,000,000 InterestAndDebtExpense 2026-06-30
ocf 15,558,000,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 79,403,000,000 Revenues 2026-06-30
sbc 131,000,000 AllocatedShareBasedCompensationExpense 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up MET on one particular measure came for.

RatioValue
cash operating margin8.59
dilution pct-5.32
ebit cagr2.71
ebit yoy14.34
fcf margin19.59
growth cv1.54
interest cover6.02
operating margin8.27
owner earnings margin19.43
revenue growth8.75
revenue growth per share14.86
roic4181.9
rule of 4017.02
sbc pct revenue0.16

What to be careful about

What this model itself distrusts about MET's figures. Written by the derivation as it ran, not added afterwards.